ClinVar Miner

Submissions for variant NM_000116.5(TAFAZZIN):c.580dup (p.Trp194fs)

dbSNP: rs2148211636
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute RCV000011852 SCV002769079 pathogenic 3-Methylglutaconic aciduria type 2 2022-02-02 criteria provided, single submitter clinical testing Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Barth syndrome (MIM#302060). (I) 0109 - This gene is associated with X-linked recessive disease. Typically female carriers do not manifest disease due to skewed X-inactivation of the mutant allele. However, affected females have been reported either due to biallelic mutation or monoallelic with skewed X-inactivation of the wild type allele (GeneReviews). (I) 0115 - Variants in this gene are known to have variable expressivity with intrafamilial variability (OMIM). (I) 0202 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction), but is located in an exon that may undergo alternative splicing. (SP) 0219 - This variant is non-coding in alternative transcripts, but is coding in the ClinVar predominant transcript. (I) 0253 - This variant is hemizygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other NMD predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity (DECIPHER). (SP) 0807 - This variant has no previous evidence of pathogenicity. It has been previously reported in this same family by Bione, S. et al. (PMID:8630491). (I) 0903 - This variant has limited evidence for segregation with disease. This variant was found in this proband, his unaffected mother and two affected male cousins (PMID: 8630491). (SP) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign
OMIM RCV000011852 SCV000032085 pathogenic 3-Methylglutaconic aciduria type 2 1996-04-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.